Hepatitis D surgery: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) |
||
| Line 8: | Line 8: | ||
The treatment of hepatitis D usually does not involve surgical procedures. | The treatment of hepatitis D usually does not involve surgical procedures. | ||
===Liver Transplantation=== | ===Liver Transplantation=== | ||
[[Liver transplant]] is indicated in patients with end-stage [[liver disease]], or [[liver failure]] secondary to [[HDV infection]], in whom treatment with [[interferon]] is not indicated. | [[Liver transplant]] is indicated in patients with end-stage [[liver disease]], or [[liver failure]] secondary to [[HDV infection]], in whom treatment with [[interferon]] is not indicated. These patients usually have a good outcome, with inhibition of HBV and HDV reinfection when simultaneously treated with nucleoside and nucleotide analogues, and hepatitis B antibodies. | ||
==References== | ==References== | ||
Revision as of 12:06, 8 August 2014
|
Hepatitis D |
|
Diagnosis |
|
Treatment |
|
Hepatitis D surgery On the Web |
|
American Roentgen Ray Society Images of Hepatitis D surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Varun Kumar, M.B.B.S. [2]; João André Alves Silva, M.D. [3] Jolanta Marszalek, M.D. [4]
Overview
Surgery
The treatment of hepatitis D usually does not involve surgical procedures.
Liver Transplantation
Liver transplant is indicated in patients with end-stage liver disease, or liver failure secondary to HDV infection, in whom treatment with interferon is not indicated. These patients usually have a good outcome, with inhibition of HBV and HDV reinfection when simultaneously treated with nucleoside and nucleotide analogues, and hepatitis B antibodies.